Back

Inhibition of DHODH Activates Pyroptosis and cGAS-STING Pathways to Enhance NK cell Infiltration Mediated Anti-tumor Immunity in Melanoma

Hai, Y.; Lin, R.; liao, W.; Fu, S.; Fan, R.; Ding, G.; Zhuang, J.; Zhang, B.; Liu, Y.; Song, J.; Wei, G.

2025-03-24 cancer biology
10.1101/2025.03.20.644471 bioRxiv
Show abstract

Cancer cells are heavily reliant on de novo pyrimidine synthesis. Suppression of pyrimidine metabolism directly inhibits tumor growth and fosters immune activation within the tumor microenvironment. Dihydroorotate dehydrogenase (DHODH), a crucial enzyme governing de novo pyrimidine synthesis, is a critical player in this context. Inhibition of DHODH not only reverses immunosuppression but also instigates a mild innate immune response. However, the impact of DHODH inhibition on natural killer (NK) cells remains unexplored. In this study, we found that inhibition of DHODH efficiently promotes NK cells infiltration in tumors. Suppression of DHODH led to increased oxidative stress in mitochondria, the release of mtDNA, and activation of caspase 3, which in turn activated the cGAS-STING pathway and pyroptosis in cancer cells, respectively, contributing to NK cells induced antitumor immune responses in melanoma. Additionally, we developed EA6, a novel DHODH inhibitor with higher efficacy in promoting NK cells infiltration. In summary, this study underscores that modulation of pyrimidine metabolism can effectively trigger antitumor immune responses, with a specific emphasis on NK cells. This finding opens new avenues for enhancing the efficacy of targeted nucleotide metabolism in cancer therapy. GRAPHICAL ABSTRACT O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=141 SRC="FIGDIR/small/644471v1_ufig1.gif" ALT="Figure 1"> View larger version (60K): org.highwire.dtl.DTLVardef@88d4fcorg.highwire.dtl.DTLVardef@156fe1aorg.highwire.dtl.DTLVardef@448086org.highwire.dtl.DTLVardef@152079c_HPS_FORMAT_FIGEXP M_FIG C_FIG The anti-tumor mechanisms of DHODH inhibition. Inhibition of DHODH activates cGAS-STING pathways to enhance NK cell infiltration. And the tumor-infiltrating NK cells facilitate melanoma cells pyroptosis which providing a positive feedback mechanism for DHODH-mediated anti-tumor immunity.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

1
Theranostics
37 papers in training set
Top 0.1%
15.2%
2
Advanced Science
286 papers in training set
Top 0.7%
6.8%
3
eLife
5828 papers in training set
Top 16%
6.8%
4
Cancer Letters
35 papers in training set
Top 0.1%
4.9%
5
Oncogene
85 papers in training set
Top 0.4%
4.4%
6
Nature Communications
5641 papers in training set
Top 32%
4.1%
7
Cancers
213 papers in training set
Top 2%
3.5%
8
iScience
1154 papers in training set
Top 10%
2.5%
9
Cell Death & Disease
126 papers in training set
Top 1%
2.4%
50% of probability mass above
10
Clinical and Translational Medicine
31 papers in training set
Top 0.2%
2.4%
11
Cell Reports
1498 papers in training set
Top 16%
2.1%
12
Cancer Immunology Research
35 papers in training set
Top 0.4%
2.1%
13
Science Advances
1243 papers in training set
Top 16%
2.1%
14
Acta Biochimica et Biophysica Sinica
23 papers in training set
Top 0.2%
1.9%
15
Communications Biology
993 papers in training set
Top 13%
1.7%
16
Redox Biology
70 papers in training set
Top 0.6%
1.7%
17
Cell Death & Differentiation
48 papers in training set
Top 0.5%
1.7%
18
Signal Transduction and Targeted Therapy
30 papers in training set
Top 0.3%
1.7%
19
Biomedicine & Pharmacotherapy
42 papers in training set
Top 0.6%
1.7%
20
International Journal of Molecular Sciences
494 papers in training set
Top 12%
1.0%
21
Molecular Therapy
81 papers in training set
Top 1%
1.0%
22
Journal for ImmunoTherapy of Cancer
75 papers in training set
Top 2%
0.9%
23
Journal of Investigative Dermatology
49 papers in training set
Top 0.6%
0.9%
24
Cancer Research
130 papers in training set
Top 3%
0.9%
25
Life Sciences
27 papers in training set
Top 1%
0.9%
26
Frontiers in Immunology
638 papers in training set
Top 9%
0.9%
27
EMBO Molecular Medicine
95 papers in training set
Top 3%
0.6%
28
Journal of Clinical Investigation
179 papers in training set
Top 6%
0.6%
29
Scientific Reports
3612 papers in training set
Top 78%
0.6%
30
Cell Death Discovery
58 papers in training set
Top 2%
0.6%